{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"vip-plantar-fasciitis","title":"VIP for Plantar Fasciitis: Immune Modulation and Tissue Repair Pathways","body":"## What's breaking down if you have Plantar fasciitis\n\nPlantar fasciitis involves degeneration of the plantar fascia, the thick connective tissue band running along the bottom of the foot from heel to toes. Microtears from repetitive overload or sudden strain outpace the tissue's natural repair capacity. This leads to failed healing, local inflammation, and thickened fascia that transmits pain on weight-bearing steps.\n\nThe layers include connective tissue breakdown, immune cell infiltration that sustains low-grade inflammation, and autonomic signaling that can influence local blood flow and pain perception. When breakdown outruns repair, symptoms persist even after initial injury resolves.\n\n## Why VIP might help you\n\nVIP targets the immune and autonomic layer. If your plantar fasciitis involves ongoing immune-driven inflammation that blocks fascia repair, VIP is discussed because it modulates cytokine balance and promotes regulatory responses rather than broadly suppressing signals.\n\n1. You are reading about Plantar fasciitis — what breaks down matters before any compound name.\n2. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n\nVIP binds receptors on immune cells and fibroblasts. In preclinical models of joint inflammation, this shifts the environment toward resolution, allowing connective tissue cells to focus on matrix production instead of chronic defense.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- VIP → immune / autonomic\n\nVIP addresses the immune/autonomic component of fascia degeneration. Other approaches might address mechanical load or direct fibroblast activity, but VIP's role stays specific to modulating the inflammatory milieu that can stall repair.\n\n## What the evidence actually shows\n\nNo human trials test VIP directly for plantar fasciitis (preclinical tier for related conditions; mechanistic tier for general effects). Animal studies in collagen-induced arthritis models (mice) show VIP administration reduces joint swelling, downregulates pro-inflammatory cytokines, and limits bone and cartilage destruction (preclinical tier). One human observational study linked higher VIP serum levels or certain gene variants to lower treatment needs in early rheumatoid arthritis patients (human tier, correlational only).\n\nWound-healing data comes from bronchial epithelial cell cultures where VIP increased proliferation via cAMP pathways (mechanistic tier). No rat or mouse studies examine VIP on plantar fascia specifically.\n\n## What scientists say\n\nReviews note VIP as an endogenous immunomodulator with potential in inflammatory joint diseases, but emphasize lack of clinical translation beyond animal models and call for more human data (mechanistic/speculative tier for plantar fasciitis application). Researchers highlight its ability to promote immune tolerance in autoimmune models without broad suppression.\n\n## What people say on Reddit\n\nAnecdotal reports on peptide forums mention VIP rarely in context of foot or heel issues; discussions center on other peptides for plantar fasciitis or general inflammation. No consistent user experiences tie VIP to fascia healing (anecdotal tier; sparse and indirect).\n\n## What people say on X\n\nSearches yield no relevant posts discussing VIP peptide for plantar fasciitis or heel pain (anecdotal tier; zero direct matches).\n\n## What we do not know\n\nDirect effects on human plantar fascia remain unknown. It is unclear whether systemic or local VIP would reach the foot fascia in meaningful amounts or alter degenerative progression versus symptoms. Weight-loss effects on plantar load (roughly 4 lb reduced compressive force per 1 lb body weight lost) are mechanical and separate from VIP pathways.\n\n## Safety and limits\n\nVIP has been studied in limited human contexts such as sarcoidosis and early arthritis for immune effects, with no major safety signals reported in those small cohorts (human tier, limited scope). Broader safety data in healthy individuals or for musculoskeletal use is absent. Individual responses vary; monitoring by a clinician remains essential. Evidence does not support VIP as a standalone solution for plantar fasciitis.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/vip-plantar-fasciitis/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No direct human trials exist for VIP in plantar fasciitis.","section":"What the evidence actually shows","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Establishes absence of condition-specific data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In mouse collagen-induced arthritis models, VIP reduced joint inflammation and tissue destruction.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:1"],"source_status":"sourced","why_material":"Provides closest preclinical analog for inflammatory joint/tissue conditions.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Higher VIP levels or related gene variants correlated with reduced treatment intensity in early rheumatoid arthritis patients.","section":"What the evidence actually shows","tier":"human","source_ids":["web:36"],"source_status":"sourced","why_material":"Offers limited human correlational evidence in arthritis.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"VIP modulates immune responses by shifting cytokine balance toward regulatory profiles in cell and animal models.","section":"Why VIP might help you","tier":"mechanistic","source_ids":["web:0"],"source_status":"sourced","why_material":"Explains proposed repair-supporting mechanism via immune layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6982157/","title":"A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases","quote":"Vasoactive intestinal peptide (VIP) is the paradigm of an endogenous neuropeptide produced during autoimmune responses and processes of systemic and local inflammation.","summary":"Review on VIP in inflammatory diseases.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:24:25.135Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"584a37b8f921aa3332ddc16f184f31edfadca3a5d0e91c7edbdf37eedc6b9cfe"},{"id":"web:1","type":"medical","url":"https://www.hopkinsarthritis.org/arthritis-news/vasoactive-intestinal-peptide-vip-prevents-experimental-arthritis-news-summary-from-johns-hopkins-arthritis/","title":"Vasoactive intestinal peptide (VIP) prevents experimental arthritis","quote":"VIP is a neuropeptide that has anti-inflammatory and immuno-modulatory properties. Its ability to suppress and prevent experimentally induced arthritis was reported by Delgado et al in Nature Medicine 7:563, 2001.","summary":"Summary of mouse CIA model results.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:24:25.135Z","link_status":"timeout","quote_status":"unverified","prev":"584a37b8f921aa3332ddc16f184f31edfadca3a5d0e91c7edbdf37eedc6b9cfe","hash":"b1039aacfd953a9ed1385e749c53eaa180e89bb249ae16e9d9d6a1bbec641e3b"},{"id":"web:36","type":"pubmed","url":"https://www.nature.com/articles/s41598-018-20400-6","title":"Vasoactive intestinal peptide gene polymorphisms... predict treatment requirements in early rheumatoid arthritis","quote":"We concluded that the identification of polymorphisms associated with VIP serum levels would complement the clinical assessment of the disease severity in rheumatoid arthritis patients.","summary":"Human study on VIP levels and RA outcomes.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:24:25.135Z","link_status":"timeout","quote_status":"unverified","prev":"b1039aacfd953a9ed1385e749c53eaa180e89bb249ae16e9d9d6a1bbec641e3b","hash":"e68986c867320341cddfb90eb0fd7969a11ce3fa1ca983832dafe1849f045ed5"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T22:24:35.397Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"VIP for Plantar Fasciitis: Immune Modulation and Tissue Repair Pathways","register":"source_ledger","body":"## What's breaking down if you have Plantar fasciitis\n\nPlantar fasciitis involves degeneration of the plantar fascia, the thick connective tissue band running along the bottom of the foot from heel to toes. Microtears from repetitive overload or sudden strain outpace the tissue's natural repair capacity. This leads to failed healing, local inflammation, and thickened fascia that transmits pain on weight-bearing steps.\n\nThe layers include connective tissue breakdown, immune cell infiltration that sustains low-grade inflammation, and autonomic signaling that can influence local blood flow and pain perception. When breakdown outruns repair, symptoms persist even after initial injury resolves.\n\n## Why VIP might help you\n\nVIP targets the immune and autonomic layer. If your plantar fasciitis involves ongoing immune-driven inflammation that blocks fascia repair, VIP is discussed because it modulates cytokine balance and promotes regulatory responses rather than broadly suppressing signals.\n\n1. You are reading about Plantar fasciitis — what breaks down matters before any compound name.\n2. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n\nVIP binds receptors on immune cells and fibroblasts. In preclinical models of joint inflammation, this shifts the environment toward resolution, allowing connective tissue cells to focus on matrix production instead of chronic defense.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- VIP → immune / autonomic\n\nVIP addresses the immune/autonomic component of fascia degeneration. Other approaches might address mechanical load or direct fibroblast activity, but VIP's role stays specific to modulating the inflammatory milieu that can stall repair.\n\n## What the evidence actually shows\n\nNo human trials test VIP directly for plantar fasciitis (preclinical tier for related conditions; mechanistic tier for general effects). Animal studies in collagen-induced arthritis models (mice) show VIP administration reduces joint swelling, downregulates pro-inflammatory cytokines, and limits bone and cartilage destruction (preclinical tier). One human observational study linked higher VIP serum levels or certain gene variants to lower treatment needs in early rheumatoid arthritis patients (human tier, correlational only).\n\nWound-healing data comes from bronchial epithelial cell cultures where VIP increased proliferation via cAMP pathways (mechanistic tier). No rat or mouse studies examine VIP on plantar fascia specifically.\n\n## What scientists say\n\nReviews note VIP as an endogenous immunomodulator with potential in inflammatory joint diseases, but emphasize lack of clinical translation beyond animal models and call for more human data (mechanistic/speculative tier for plantar fasciitis application). Researchers highlight its ability to promote immune tolerance in autoimmune models without broad suppression.\n\n## What people say on Reddit\n\nAnecdotal reports on peptide forums mention VIP rarely in context of foot or heel issues; discussions center on other peptides for plantar fasciitis or general inflammation. No consistent user experiences tie VIP to fascia healing (anecdotal tier; sparse and indirect).\n\n## What people say on X\n\nSearches yield no relevant posts discussing VIP peptide for plantar fasciitis or heel pain (anecdotal tier; zero direct matches).\n\n## What we do not know\n\nDirect effects on human plantar fascia remain unknown. It is unclear whether systemic or local VIP would reach the foot fascia in meaningful amounts or alter degenerative progression versus symptoms. Weight-loss effects on plantar load (roughly 4 lb reduced compressive force per 1 lb body weight lost) are mechanical and separate from VIP pathways.\n\n## Safety and limits\n\nVIP has been studied in limited human contexts such as sarcoidosis and early arthritis for immune effects, with no major safety signals reported in those small cohorts (human tier, limited scope). Broader safety data in healthy individuals or for musculoskeletal use is absent. Individual responses vary; monitoring by a clinician remains essential. Evidence does not support VIP as a standalone solution for plantar fasciitis.","claims":[{"id":"c1","text":"No direct human trials exist for VIP in plantar fasciitis.","section":"What the evidence actually shows","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Establishes absence of condition-specific data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In mouse collagen-induced arthritis models, VIP reduced joint inflammation and tissue destruction.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:1"],"source_status":"sourced","why_material":"Provides closest preclinical analog for inflammatory joint/tissue conditions.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Higher VIP levels or related gene variants correlated with reduced treatment intensity in early rheumatoid arthritis patients.","section":"What the evidence actually shows","tier":"human","source_ids":["web:36"],"source_status":"sourced","why_material":"Offers limited human correlational evidence in arthritis.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"VIP modulates immune responses by shifting cytokine balance toward regulatory profiles in cell and animal models.","section":"Why VIP might help you","tier":"mechanistic","source_ids":["web:0"],"source_status":"sourced","why_material":"Explains proposed repair-supporting mechanism via immune layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6982157/","title":"A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases","quote":"Vasoactive intestinal peptide (VIP) is the paradigm of an endogenous neuropeptide produced during autoimmune responses and processes of systemic and local inflammation.","link_status":"ok","quote_status":"verified"},{"id":"web:1","type":"medical","url":"https://www.hopkinsarthritis.org/arthritis-news/vasoactive-intestinal-peptide-vip-prevents-experimental-arthritis-news-summary-from-johns-hopkins-arthritis/","title":"Vasoactive intestinal peptide (VIP) prevents experimental arthritis","quote":"VIP is a neuropeptide that has anti-inflammatory and immuno-modulatory properties. Its ability to suppress and prevent experimentally induced arthritis was reported by Delgado et al in Nature Medicine 7:563, 2001.","link_status":"timeout","quote_status":"unverified"},{"id":"web:36","type":"pubmed","url":"https://www.nature.com/articles/s41598-018-20400-6","title":"Vasoactive intestinal peptide gene polymorphisms... predict treatment requirements in early rheumatoid arthritis","quote":"We concluded that the identification of polymorphisms associated with VIP serum levels would complement the clinical assessment of the disease severity in rheumatoid arthritis patients.","link_status":"timeout","quote_status":"unverified"}]},"rationale":"","tokens_in":25979,"tokens_out":2609,"cost":0.03899625,"prev_hash":"genesis","hash":"4f7b2c8d3b05b4d8a9ce1457e90643985799ab6f6040ef9adf47816a45cb0810"}],"provenance":[{"ts":"2026-06-29T22:24:35.397Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Vip for Plantar Fasciitis\nSlug: vip-plantar-fasciitis\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Plantar fasciitis\",\"condition_key\":\"plantar-fasciitis\",\"primary_peptide\":\"vip\",\"peptides_in_scope\":[{\"id\":\"vip\",\"name\":\"VIP\"}],\"drugs_in_scope\":[],\"weight_sensitive\":true,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Plantar fasciitis\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"vip\",\"name\":\"VIP\",\"section_title\":\"Why VIP might help you\",\"layer\":\"immune / autonomic\",\"steps\":[\"You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **VIP** → immune / autonomic\",\"section_headings\":[\"What's breaking down if you have Plantar fasciitis\",\"Why VIP might help you\",\"How these fit together\",\"What the evidence actually shows\",\"","response":"{\n  \"slug\": \"vip-plantar-fasciitis\",\n  \"title\": \"VIP for Plantar Fasciitis: Immune Modulation and Tissue Repair Pathways\",\n  \"body\": \"## What's breaking down if you have Plantar fasciitis\\n\\nPlantar fasciitis involves degeneration of the plantar fascia, the thick connective tissue band running along the bottom of the foot from heel to toes. Microtears from repetitive overload or sudden strain outpace the tissue's natural repair capacity. This leads to failed healing, local inflammation, and thickened fascia that transmits pain on weight-bearing steps.\\n\\nThe layers include connective tissue breakdown, immune cell infiltration that sustains low-grade inflammation, and autonomic signaling that can influence local blood flow and pain perception. When breakdown outruns repair, symptoms persist even after initial injury resolves.\\n\\n## Why VIP might help you\\n\\nVIP targets the immune and autonomic layer. If your plantar fasciitis involves ongoing immune-driven inflammation that blocks fascia repair, VIP is discussed because it modulates cytokine balance and promotes regulatory responses rather than broadly suppressing signals.\\n\\n1. You are reading about Plantar fasciitis — what breaks down matters before any compound name.\\n2. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nVIP binds receptors on immune cells and fibroblasts. In preclinical models of joint inflammation, this shifts the environment toward resolution, allowing connective tissue cells to focus on matrix production instead of chronic defense.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- VIP → immune / autonomic\\n\\nVIP addresses the immune/autonomic component of fascia degeneration. Other approaches might address mechanical load or direct fibroblast activity, but VIP's role stays spec","tokens_in":25979,"tokens_out":2609,"cost":0,"prev":"genesis","hash":"56bde34e860cbe58f011c028c2ff07b8a97c31eb19128816c509782ed8000bd0"},{"ts":"2026-07-17T02:43:26.243Z","model":"owner","action":"voxel_divide","prompt":"","input":"vip-plantar-fasciitis","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"56bde34e860cbe58f011c028c2ff07b8a97c31eb19128816c509782ed8000bd0","hash":"3847a8cf8db2464f74c863e8fc128c1b27d216ae0c07b2f343c76bb5dbfe09d0"}],"energy":{"passes":2,"tokens_in":25979,"tokens_out":2609,"tokens_total":28588,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"3847a8cf8db2464f74c863e8fc128c1b27d216ae0c07b2f343c76bb5dbfe09d0"},"posted_at":"2026-06-29T21:33:51.761Z","created_at":"2026-06-29T21:33:51.761Z","updated_at":"2026-07-17T02:43:26.243Z","machine":{"shape":"article.machine/v1","slug":"vip-plantar-fasciitis","kind":"article","read":{"human":"https://miscsubjects.com/a/vip-plantar-fasciitis","json":"https://miscsubjects.com/api/articles/vip-plantar-fasciitis","bundle":"https://miscsubjects.com/api/articles/vip-plantar-fasciitis/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/vip-plantar-fasciitis/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=vip-plantar-fasciitis","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"vip-plantar-fasciitis\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"vip-plantar-fasciitis\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/vip-plantar-fasciitis/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"vip-plantar-fasciitis\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/vip-plantar-fasciitis | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/vip-plantar-fasciitis","json":"/api/articles/vip-plantar-fasciitis","markdown":"/api/articles/vip-plantar-fasciitis/bundle?format=markdown","skill":"/api/articles/vip-plantar-fasciitis/skill","topology":"/api/articles/vip-plantar-fasciitis/topology","versions":"/api/articles/vip-plantar-fasciitis/revisions","invocations":"/api/articles/vip-plantar-fasciitis/invocations"},"editorial_review":null,"editorial_audit":{"slug":"vip-plantar-fasciitis","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"8f1251d98055faabc25686da2a6e9e88dda3e8cfd5bc17fb46a6ebaad7f8a1d9","object":{"object_type":"article-object","identity":{"id":"article:vip-plantar-fasciitis","slug":"vip-plantar-fasciitis","title":"VIP for Plantar Fasciitis: Immune Modulation and Tissue Repair Pathways"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/vip-plantar-fasciitis","role":"explain","audience":"human"},"skill":{"route":"/api/articles/vip-plantar-fasciitis/skill","role":"direct behavior","audience":"model","content":"---\nname: vip-plantar-fasciitis\ndescription: Apply the VIP for Plantar Fasciitis: Immune Modulation and Tissue Repair Pathways article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# VIP for Plantar Fasciitis: Immune Modulation and Tissue Repair Pathways\n\nThis Skill is the behavioral expression of [the canonical article](/a/vip-plantar-fasciitis). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/vip-plantar-fasciitis.\n- Read claims and relationships at /api/articles/vip-plantar-fasciitis/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down if you have Plantar fasciitis Plantar fasciitis involves degeneration of the plantar fascia, the thick connective tissue band running along the bottom of the foot from heel to toes. Microtears from repetitive overload o\n\n## Representations\n\n- Human: /a/vip-plantar-fasciitis\n- JSON: /api/articles/vip-plantar-fasciitis\n- Relationships: /api/articles/vip-plantar-fasciitis/topology\n- History: /api/articles/vip-plantar-fasciitis/revisions\n"},"json":{"route":"/api/articles/vip-plantar-fasciitis","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/vip-plantar-fasciitis/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","vip","plantar","fasciitis"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/vip-plantar-fasciitis/invocations?status=success","failure_events":"/api/articles/vip-plantar-fasciitis/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"vip-plantar-fasciitis","title":"VIP for Plantar Fasciitis: Immune Modulation and Tissue Repair Pathways","body":"## What's breaking down if you have Plantar fasciitis\n\nPlantar fasciitis involves degeneration of the plantar fascia, the thick connective tissue band running along the bottom of the foot from heel to toes. Microtears from repetitive overload or sudden strain outpace the tissue's natural repair capacity. This leads to failed healing, local inflammation, and thickened fascia that transmits pain on weight-bearing steps.\n\nThe layers include connective tissue breakdown, immune cell infiltration that sustains low-grade inflammation, and autonomic signaling that can influence local blood flow and pain perception. When breakdown outruns repair, symptoms persist even after initial injury resolves.\n\n## Why VIP might help you\n\nVIP targets the immune and autonomic layer. If your plantar fasciitis involves ongoing immune-driven inflammation that blocks fascia repair, VIP is discussed because it modulates cytokine balance and promotes regulatory responses rather than broadly suppressing signals.\n\n1. You are reading about Plantar fasciitis — what breaks down matters before any compound name.\n2. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n\nVIP binds receptors on immune cells and fibroblasts. In preclinical models of joint inflammation, this shifts the environment toward resolution, allowing connective tissue cells to focus on matrix production instead of chronic defense.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- VIP → immune / autonomic\n\nVIP addresses the immune/autonomic component of fascia degeneration. Other approaches might address mechanical load or direct fibroblast activity, but VIP's role stays specific to modulating the inflammatory milieu that can stall repair.\n\n## What the evidence actually shows\n\nNo human trials test VIP directly for plantar fasciitis (preclinical tier for related conditions; mechanistic tier for general effects). Animal studies in collagen-induced arthritis models (mice) show VIP administration reduces joint swelling, downregulates pro-inflammatory cytokines, and limits bone and cartilage destruction (preclinical tier). One human observational study linked higher VIP serum levels or certain gene variants to lower treatment needs in early rheumatoid arthritis patients (human tier, correlational only).\n\nWound-healing data comes from bronchial epithelial cell cultures where VIP increased proliferation via cAMP pathways (mechanistic tier). No rat or mouse studies examine VIP on plantar fascia specifically.\n\n## What scientists say\n\nReviews note VIP as an endogenous immunomodulator with potential in inflammatory joint diseases, but emphasize lack of clinical translation beyond animal models and call for more human data (mechanistic/speculative tier for plantar fasciitis application). Researchers highlight its ability to promote immune tolerance in autoimmune models without broad suppression.\n\n## What people say on Reddit\n\nAnecdotal reports on peptide forums mention VIP rarely in context of foot or heel issues; discussions center on other peptides for plantar fasciitis or general inflammation. No consistent user experiences tie VIP to fascia healing (anecdotal tier; sparse and indirect).\n\n## What people say on X\n\nSearches yield no relevant posts discussing VIP peptide for plantar fasciitis or heel pain (anecdotal tier; zero direct matches).\n\n## What we do not know\n\nDirect effects on human plantar fascia remain unknown. It is unclear whether systemic or local VIP would reach the foot fascia in meaningful amounts or alter degenerative progression versus symptoms. Weight-loss effects on plantar load (roughly 4 lb reduced compressive force per 1 lb body weight lost) are mechanical and separate from VIP pathways.\n\n## Safety and limits\n\nVIP has been studied in limited human contexts such as sarcoidosis and early arthritis for immune effects, with no major safety signals reported in those small cohorts (human tier, limited scope). Broader safety data in healthy individuals or for musculoskeletal use is absent. Individual responses vary; monitoring by a clinician remains essential. Evidence does not support VIP as a standalone solution for plantar fasciitis.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/vip-plantar-fasciitis/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No direct human trials exist for VIP in plantar fasciitis.","section":"What the evidence actually shows","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Establishes absence of condition-specific data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In mouse collagen-induced arthritis models, VIP reduced joint inflammation and tissue destruction.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:1"],"source_status":"sourced","why_material":"Provides closest preclinical analog for inflammatory joint/tissue conditions.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Higher VIP levels or related gene variants correlated with reduced treatment intensity in early rheumatoid arthritis patients.","section":"What the evidence actually shows","tier":"human","source_ids":["web:36"],"source_status":"sourced","why_material":"Offers limited human correlational evidence in arthritis.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"VIP modulates immune responses by shifting cytokine balance toward regulatory profiles in cell and animal models.","section":"Why VIP might help you","tier":"mechanistic","source_ids":["web:0"],"source_status":"sourced","why_material":"Explains proposed repair-supporting mechanism via immune layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6982157/","title":"A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases","quote":"Vasoactive intestinal peptide (VIP) is the paradigm of an endogenous neuropeptide produced during autoimmune responses and processes of systemic and local inflammation.","summary":"Review on VIP in inflammatory diseases.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:24:25.135Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"584a37b8f921aa3332ddc16f184f31edfadca3a5d0e91c7edbdf37eedc6b9cfe"},{"id":"web:1","type":"medical","url":"https://www.hopkinsarthritis.org/arthritis-news/vasoactive-intestinal-peptide-vip-prevents-experimental-arthritis-news-summary-from-johns-hopkins-arthritis/","title":"Vasoactive intestinal peptide (VIP) prevents experimental arthritis","quote":"VIP is a neuropeptide that has anti-inflammatory and immuno-modulatory properties. Its ability to suppress and prevent experimentally induced arthritis was reported by Delgado et al in Nature Medicine 7:563, 2001.","summary":"Summary of mouse CIA model results.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:24:25.135Z","link_status":"timeout","quote_status":"unverified","prev":"584a37b8f921aa3332ddc16f184f31edfadca3a5d0e91c7edbdf37eedc6b9cfe","hash":"b1039aacfd953a9ed1385e749c53eaa180e89bb249ae16e9d9d6a1bbec641e3b"},{"id":"web:36","type":"pubmed","url":"https://www.nature.com/articles/s41598-018-20400-6","title":"Vasoactive intestinal peptide gene polymorphisms... predict treatment requirements in early rheumatoid arthritis","quote":"We concluded that the identification of polymorphisms associated with VIP serum levels would complement the clinical assessment of the disease severity in rheumatoid arthritis patients.","summary":"Human study on VIP levels and RA outcomes.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:24:25.135Z","link_status":"timeout","quote_status":"unverified","prev":"b1039aacfd953a9ed1385e749c53eaa180e89bb249ae16e9d9d6a1bbec641e3b","hash":"e68986c867320341cddfb90eb0fd7969a11ce3fa1ca983832dafe1849f045ed5"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T22:24:35.397Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"VIP for Plantar Fasciitis: Immune Modulation and Tissue Repair Pathways","register":"source_ledger","body":"## What's breaking down if you have Plantar fasciitis\n\nPlantar fasciitis involves degeneration of the plantar fascia, the thick connective tissue band running along the bottom of the foot from heel to toes. Microtears from repetitive overload or sudden strain outpace the tissue's natural repair capacity. This leads to failed healing, local inflammation, and thickened fascia that transmits pain on weight-bearing steps.\n\nThe layers include connective tissue breakdown, immune cell infiltration that sustains low-grade inflammation, and autonomic signaling that can influence local blood flow and pain perception. When breakdown outruns repair, symptoms persist even after initial injury resolves.\n\n## Why VIP might help you\n\nVIP targets the immune and autonomic layer. If your plantar fasciitis involves ongoing immune-driven inflammation that blocks fascia repair, VIP is discussed because it modulates cytokine balance and promotes regulatory responses rather than broadly suppressing signals.\n\n1. You are reading about Plantar fasciitis — what breaks down matters before any compound name.\n2. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n\nVIP binds receptors on immune cells and fibroblasts. In preclinical models of joint inflammation, this shifts the environment toward resolution, allowing connective tissue cells to focus on matrix production instead of chronic defense.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- VIP → immune / autonomic\n\nVIP addresses the immune/autonomic component of fascia degeneration. Other approaches might address mechanical load or direct fibroblast activity, but VIP's role stays specific to modulating the inflammatory milieu that can stall repair.\n\n## What the evidence actually shows\n\nNo human trials test VIP directly for plantar fasciitis (preclinical tier for related conditions; mechanistic tier for general effects). Animal studies in collagen-induced arthritis models (mice) show VIP administration reduces joint swelling, downregulates pro-inflammatory cytokines, and limits bone and cartilage destruction (preclinical tier). One human observational study linked higher VIP serum levels or certain gene variants to lower treatment needs in early rheumatoid arthritis patients (human tier, correlational only).\n\nWound-healing data comes from bronchial epithelial cell cultures where VIP increased proliferation via cAMP pathways (mechanistic tier). No rat or mouse studies examine VIP on plantar fascia specifically.\n\n## What scientists say\n\nReviews note VIP as an endogenous immunomodulator with potential in inflammatory joint diseases, but emphasize lack of clinical translation beyond animal models and call for more human data (mechanistic/speculative tier for plantar fasciitis application). Researchers highlight its ability to promote immune tolerance in autoimmune models without broad suppression.\n\n## What people say on Reddit\n\nAnecdotal reports on peptide forums mention VIP rarely in context of foot or heel issues; discussions center on other peptides for plantar fasciitis or general inflammation. No consistent user experiences tie VIP to fascia healing (anecdotal tier; sparse and indirect).\n\n## What people say on X\n\nSearches yield no relevant posts discussing VIP peptide for plantar fasciitis or heel pain (anecdotal tier; zero direct matches).\n\n## What we do not know\n\nDirect effects on human plantar fascia remain unknown. It is unclear whether systemic or local VIP would reach the foot fascia in meaningful amounts or alter degenerative progression versus symptoms. Weight-loss effects on plantar load (roughly 4 lb reduced compressive force per 1 lb body weight lost) are mechanical and separate from VIP pathways.\n\n## Safety and limits\n\nVIP has been studied in limited human contexts such as sarcoidosis and early arthritis for immune effects, with no major safety signals reported in those small cohorts (human tier, limited scope). Broader safety data in healthy individuals or for musculoskeletal use is absent. Individual responses vary; monitoring by a clinician remains essential. Evidence does not support VIP as a standalone solution for plantar fasciitis.","claims":[{"id":"c1","text":"No direct human trials exist for VIP in plantar fasciitis.","section":"What the evidence actually shows","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Establishes absence of condition-specific data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In mouse collagen-induced arthritis models, VIP reduced joint inflammation and tissue destruction.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:1"],"source_status":"sourced","why_material":"Provides closest preclinical analog for inflammatory joint/tissue conditions.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Higher VIP levels or related gene variants correlated with reduced treatment intensity in early rheumatoid arthritis patients.","section":"What the evidence actually shows","tier":"human","source_ids":["web:36"],"source_status":"sourced","why_material":"Offers limited human correlational evidence in arthritis.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"VIP modulates immune responses by shifting cytokine balance toward regulatory profiles in cell and animal models.","section":"Why VIP might help you","tier":"mechanistic","source_ids":["web:0"],"source_status":"sourced","why_material":"Explains proposed repair-supporting mechanism via immune layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:24:34.557Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6982157/","title":"A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases","quote":"Vasoactive intestinal peptide (VIP) is the paradigm of an endogenous neuropeptide produced during autoimmune responses and processes of systemic and local inflammation.","link_status":"ok","quote_status":"verified"},{"id":"web:1","type":"medical","url":"https://www.hopkinsarthritis.org/arthritis-news/vasoactive-intestinal-peptide-vip-prevents-experimental-arthritis-news-summary-from-johns-hopkins-arthritis/","title":"Vasoactive intestinal peptide (VIP) prevents experimental arthritis","quote":"VIP is a neuropeptide that has anti-inflammatory and immuno-modulatory properties. Its ability to suppress and prevent experimentally induced arthritis was reported by Delgado et al in Nature Medicine 7:563, 2001.","link_status":"timeout","quote_status":"unverified"},{"id":"web:36","type":"pubmed","url":"https://www.nature.com/articles/s41598-018-20400-6","title":"Vasoactive intestinal peptide gene polymorphisms... predict treatment requirements in early rheumatoid arthritis","quote":"We concluded that the identification of polymorphisms associated with VIP serum levels would complement the clinical assessment of the disease severity in rheumatoid arthritis patients.","link_status":"timeout","quote_status":"unverified"}]},"rationale":"","tokens_in":25979,"tokens_out":2609,"cost":0.03899625,"prev_hash":"genesis","hash":"4f7b2c8d3b05b4d8a9ce1457e90643985799ab6f6040ef9adf47816a45cb0810"}],"provenance":[{"ts":"2026-06-29T22:24:35.397Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Vip for Plantar Fasciitis\nSlug: vip-plantar-fasciitis\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Plantar fasciitis\",\"condition_key\":\"plantar-fasciitis\",\"primary_peptide\":\"vip\",\"peptides_in_scope\":[{\"id\":\"vip\",\"name\":\"VIP\"}],\"drugs_in_scope\":[],\"weight_sensitive\":true,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Plantar fasciitis\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"vip\",\"name\":\"VIP\",\"section_title\":\"Why VIP might help you\",\"layer\":\"immune / autonomic\",\"steps\":[\"You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **VIP** → immune / autonomic\",\"section_headings\":[\"What's breaking down if you have Plantar fasciitis\",\"Why VIP might help you\",\"How these fit together\",\"What the evidence actually shows\",\"","response":"{\n  \"slug\": \"vip-plantar-fasciitis\",\n  \"title\": \"VIP for Plantar Fasciitis: Immune Modulation and Tissue Repair Pathways\",\n  \"body\": \"## What's breaking down if you have Plantar fasciitis\\n\\nPlantar fasciitis involves degeneration of the plantar fascia, the thick connective tissue band running along the bottom of the foot from heel to toes. Microtears from repetitive overload or sudden strain outpace the tissue's natural repair capacity. This leads to failed healing, local inflammation, and thickened fascia that transmits pain on weight-bearing steps.\\n\\nThe layers include connective tissue breakdown, immune cell infiltration that sustains low-grade inflammation, and autonomic signaling that can influence local blood flow and pain perception. When breakdown outruns repair, symptoms persist even after initial injury resolves.\\n\\n## Why VIP might help you\\n\\nVIP targets the immune and autonomic layer. If your plantar fasciitis involves ongoing immune-driven inflammation that blocks fascia repair, VIP is discussed because it modulates cytokine balance and promotes regulatory responses rather than broadly suppressing signals.\\n\\n1. You are reading about Plantar fasciitis — what breaks down matters before any compound name.\\n2. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nVIP binds receptors on immune cells and fibroblasts. In preclinical models of joint inflammation, this shifts the environment toward resolution, allowing connective tissue cells to focus on matrix production instead of chronic defense.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- VIP → immune / autonomic\\n\\nVIP addresses the immune/autonomic component of fascia degeneration. Other approaches might address mechanical load or direct fibroblast activity, but VIP's role stays spec","tokens_in":25979,"tokens_out":2609,"cost":0,"prev":"genesis","hash":"56bde34e860cbe58f011c028c2ff07b8a97c31eb19128816c509782ed8000bd0"},{"ts":"2026-07-17T02:43:26.243Z","model":"owner","action":"voxel_divide","prompt":"","input":"vip-plantar-fasciitis","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"56bde34e860cbe58f011c028c2ff07b8a97c31eb19128816c509782ed8000bd0","hash":"3847a8cf8db2464f74c863e8fc128c1b27d216ae0c07b2f343c76bb5dbfe09d0"}],"energy":{"passes":2,"tokens_in":25979,"tokens_out":2609,"tokens_total":28588,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"3847a8cf8db2464f74c863e8fc128c1b27d216ae0c07b2f343c76bb5dbfe09d0"},"posted_at":"2026-06-29T21:33:51.761Z","created_at":"2026-06-29T21:33:51.761Z","updated_at":"2026-07-17T02:43:26.243Z","machine":{"shape":"article.machine/v1","slug":"vip-plantar-fasciitis","kind":"article","read":{"human":"https://miscsubjects.com/a/vip-plantar-fasciitis","json":"https://miscsubjects.com/api/articles/vip-plantar-fasciitis","bundle":"https://miscsubjects.com/api/articles/vip-plantar-fasciitis/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/vip-plantar-fasciitis/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=vip-plantar-fasciitis","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"vip-plantar-fasciitis\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"vip-plantar-fasciitis\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/vip-plantar-fasciitis/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"vip-plantar-fasciitis\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/vip-plantar-fasciitis | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/vip-plantar-fasciitis","json":"/api/articles/vip-plantar-fasciitis","markdown":"/api/articles/vip-plantar-fasciitis/bundle?format=markdown","skill":"/api/articles/vip-plantar-fasciitis/skill","topology":"/api/articles/vip-plantar-fasciitis/topology","versions":"/api/articles/vip-plantar-fasciitis/revisions","invocations":"/api/articles/vip-plantar-fasciitis/invocations"},"editorial_review":null,"editorial_audit":{"slug":"vip-plantar-fasciitis","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"8f1251d98055faabc25686da2a6e9e88dda3e8cfd5bc17fb46a6ebaad7f8a1d9"}}}